ADMA vs. AMSC

In the year-to-date period, ADMA achieves a 284.96% return, which is significantly higher than AMSC's 125.76% return. Over the past 10 years, ADMA has underperformed AMSC with an annualized return of 4.61%, while AMSC has yielded a comparatively higher 12.00% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ADMA Sharpe Ratio is 4.97, which is higher than the AMSC Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of ADMA and AMSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ADMA nor AMSC has paid dividends to shareholders.

The maximum ADMA drawdown since its inception was -91.28%, smaller than the maximum AMSC drawdown of -99.57%. Use the drawdown chart below to compare losses from any high point for ADMA and AMSC. For additional features, visit the drawdowns tool.

The current volatility for ADMA Biologics, Inc. (ADMA) is 13.24%, while American Superconductor Corporation (AMSC) has a volatility of 24.56%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than AMSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and American Superconductor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.